Back to Journals » Integrated Blood Pressure Control » Volume 9
Clinical Trial Report
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor, a cardiovascular risk marker: results from a randomized, double-blind, placebo-controlled, multicenter North American clinical trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
79,914 | Dovepress* | 40,331+ | 3,780 | 44,111 | |
PubMed Central* | 39,583 | 1,973 | 41,556 | ||
Totals | 79,914 | 5,753 | 85,667 | ||
*Since 13 October 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
98 | 2 | 0 | 0 | 31 | 65 |
View citations on PubMed and Google Scholar